INTERNATIONAL PHARMACEUTICAL QUALITY
Inside the Global Regulatory Dialogue

[membership level=”0,4″][The content continues for paid members only.] Login or Subscribe [/membership][membership level=”1,5,6,7,8,9,10,11,12″][membership] In a two-page document released by the Office of Pharmaceutical Quality, FDA clarifies the reporting category for a postapproval change in the supplier of a hard gelatin capsule shell. The policy explains that when an applicant changes the supplier of a hard gelatin capsule shell, with no change in capsule composition or appearance, the information should be submitted in an annual report.  However, changes in size, color or dye, or a change from gelatin to non-gelatin alternative, should be categorized as a prior approval supplement (PAS).
[/membership]